Purinergic receptor expression in the regenerating epidermis in a rat model of normal and delayed wound healing

被引:29
作者
Greig, AVH
James, SE
McGrouther, DA
Terenghi, G
Burnstock, G
机构
[1] UCL Royal Free & Univ Coll Med Sch, Auton Neurosci Inst, London NW3 2PF, England
[2] UCL Royal Free & Univ Coll Med Sch, Dept Surg, Blond McIndoe Ctr, London, England
[3] Wythenshawe Hosp, Dept Plast & Reconstruct Surg, Manchester M23 9LT, Lancs, England
关键词
denervation; keratinocyte; nerve growth factor; receptors; purinergic P2; wound healing;
D O I
10.1111/j.0906-6705.2003.00110.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
This study investigated changes in the protein expression of purinergic receptors in the regenerating rat epidermis during normal wound healing, in denervated wounds, and in denervated wounds treated with nerve growth factor (NGF), where wound healing rates are normalized. Excisional wounds were placed within denervated, pedicled, oblique, groin skin flaps, and in the contralateral abdomen to act as a control site. Six rats had NGF-treated wounds and six had untreated wounds. Tissue was harvested at day four after wounding. The re-epithelializing wound edges were analyzed immunohistochemically for P2X(5), P2X(7), P2Y(1) and P2Y(2) receptors, and immunostaining of keratinocytes was quantified using optical densitometry. In normal rat epidermis, P2Y(1) and P2Y(2) receptors were found in the basal layer where keratinocytes proliferate; P2X(5) receptors were associated with proliferating and differentiating epidermal keratinocytes in basal and suprabasal layers; P2X(7) receptors were associated with terminally differentiated keratinocytes in the stratum corneum. In the regenerating epidermis of denervated wounds, P2Y(1) receptor protein expression was significantly increased in keratinocytes (P < 0.001) but P2Y(2) receptor protein expression was significantly decreased (P < 0.001). Conversely, NGF treatment of denervated wounds, reduced expression of P2Y(1) receptors (P < 0.001) in keratinocytes but enhanced expression of the P2Y(2) receptors (P < 0.01) compared with untreated denervated wounds. In innervated wounds, NGF treatment enhanced P2X(5) (P < 0.001) and P2Y(1) receptor protein (P < 0.001) expression in keratinocytes. P2X(7) receptors were absent in all experimental wound healing preparations. P2X(5), P2X(7), P2Y(1) and P2Y(2) receptor protein expression in the regenerating epidermis was altered both during wound healing and also by NGF treatment. Possible roles for purinergic signalling and its relation to NGF in wound healing are discussed.
引用
收藏
页码:860 / 871
页数:12
相关论文
共 46 条
[1]   PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS [J].
ABBRACCHIO, MP ;
BURNSTOCK, G .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) :445-475
[2]   Purinergic signalling: Pathophysiological roles [J].
Abbracchio, MP ;
Burnstock, G .
JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (02) :113-145
[3]   Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases [J].
Berchtold, S ;
Ogilvie, ALJ ;
Bogdan, C ;
Mühl-Zürbes, P ;
Ogilvie, A ;
Schuler, G ;
Steinkasserer, A .
FEBS LETTERS, 1999, 458 (03) :424-428
[4]   Purinergic signaling and vascular cell proliferation and death [J].
Burnstock, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (03) :364-373
[5]   Overview of P2 receptors: Possible functions in immune cells [J].
Burnstock, G .
DRUG DEVELOPMENT RESEARCH, 2001, 53 (2-3) :53-59
[6]  
Burnstock G., 1978, CELL MEMBRAIN RECEPT, P107, DOI DOI 10.1016/0014-5793(79)81367-8
[7]  
Charpin C, 1996, AM J CLIN PATHOL, V106, P640
[8]   Tissue distribution of the P2X(7) receptor [J].
Collo, G ;
Neidhart, S ;
Kawashima, E ;
KoscoVilbois, M ;
North, RA ;
Buell, G .
NEUROPHARMACOLOGY, 1997, 36 (09) :1277-1283
[9]   Identification of a novel human ADP receptor coupled to Gi [J].
Communi, D ;
Gonzalez, NS ;
Detheux, M ;
Brézillon, S ;
Lannoy, V ;
Parmentier, M ;
Boeynaems, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :41479-41485
[10]   Regulation of epidermal homeostasis through P2Y2 receptors [J].
Dixon, CJ ;
Bowler, WB ;
Littlewood-Evans, A ;
Dillon, JP ;
Bilbe, G ;
Sharpe, GR ;
Gallagher, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (07) :1680-1686